About Modella
Modella is a company based in Boston (United States) founded in 2024 by Jill Stefanelli was acquired by Astrazeneca in January 2026. It operates as a B2B and SaaS. Modella offers products and services including PathChat and Judith. Modella operates in a competitive market with competitors including PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others.
- Headquarter Boston, United States
- Founders Jill Stefanelli
-
Sectors
Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Astrazeneca
(Jan 13, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Modella
Modella offers a comprehensive portfolio of products and services, including PathChat and Judith.
AI tool for summarizing and creating pathology reports.
Platform for automating AI models in biomedical analysis.
Funding Insights of Modella
Detailed funding history for Modella
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Modella
Modella has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Astrazeneca.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical and biologics products are developed and distributed worldwide.
|
Locked | Locked | Locked |
Investor details for Modella
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Modella
Investment portfolio details for Modella
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Modella
Detailed financials for Modella
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Modella Comparisons
Peer comparison for Modella
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Modella
Modella operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
|
| Locked | Locked | Locked |
Platform offering solutions for preventive health scans
|
|
| Locked | Locked | Locked |
Imaging systems and AI software for microscopes are developed.
|
Detailed competitors of Modella
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Modella
Complete news archive for Modella
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Modella
Modella was founded in 2024.
Modella is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Jill Stefanelli is the current CEO of Modella. They have also founded this company.
Modella AI is a biomedical AI company based in Boston, Massachusetts, focusing on creating innovative AI models that integrate multimodal data for pathology diagnostics and therapeutic workflows. They offer products like PathChat, an AI copilot for summarizing pathology reports, and Judith, a tool for automating AI development in biomedical image analysis. The interdisciplinary team of scientists and clinicians works to enhance healthcare outcomes through advanced AI applications.
Modella's top competitors include Aignostics, Pictor Labs and PathAI.
Modella offers PathChat and Judith.
Modella has 1 investor. Key investors include Astrazeneca.